BioPhorum celebrates its 200th membership
Founded in 2008 with one Phorum, Drug Substance, the BioPhorum collaboration has focused on bringing leaders and SMEs together, mobilizing communities, creating partnerships and replacing isolation with collaboration. No...
How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Surv...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
Regulatory compliance: what lessons can be learned?
The person responsible for regulatory compliance (PRRC) is a new role, as defined in the European medical devices and in...
Navigating the maze of medical technology regulation: a solo voyage or a team effort?
Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range...
BioPhorum celebrates its 200th membership
Founded in 2008 with one Phorum, Drug Substance, the BioPhorum collaboration has focused on bringing leaders and SMEs to...
How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Surv...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
Regulatory compliance: what lessons can be learned?
The person responsible for regulatory compliance (PRRC) is a new role, as defined in the European medical devices and in...
Navigating the maze of medical technology regulation: a solo voyage or a team effort?
Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range...
